Applications Published 13 December 2000

Published: 25-Aug-2001

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Pharmaceutical compsns containing the phospholipase inhibitor sodium 3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-phenylmethyl)-1H-indol-4-yl]oxy]acetate
    Shionogi & Co; Eli Lilly 1058547*

  • New use
    AstraZeneca 1058548*
  • Thrombin or factor XA inhibitors
    DuPont Pharmaceuticals 1058549*

  • Substituted semicarbazides and the use thereof
    Euro-Celtique 1058550*

  • Use of D1/D5 antagonists for treating osessive compulsive disorders, dissociative disorders, eating disorders, impulse control disorders and autism
    Schering 1058551*

  • Steroid derived antibiotics
    Brigham Young University 1058552*

  • Pharmaceutical compsn for prophylaxis and therapy of diseases and therapy of diseases associated with occular fundus tissue cytopathy
    Senju Pharmaceutical 1058553*

  • Nontoxic vernix compsn and method of producing
    Children's Hospital Medical Centre 1058554*

  • Costimulatory blockade and mixed chimerism in allotransplantation
    The General Hospital Corporation 1058555*

  • Spray drying of pharmaceutical formulations containing amino acid-based materials
    Applied Analytical Industries 1058556*

  • Enhancement of immunity by intranasal inoculation of IL-12
    The Medical College of Ohio 1058557*

  • Live recombinant vaccines injected with adjuvant
    Merial 1058558*

  • Combination of a selective NMDA antagonist and a COX-2 inhibitor
    Merck Sharp & Dohme 1058559*

  • Topical ophthalmic preparations containing immunosupressive agents
    Galena 1058560*

  • Solubilising delivery systems and method of manufacture
    Bioval International 1058561*

  • Compsns and methods for treating tumours
    The Trustees of the University of Pennsylvania 1058562*

  • Systems and methods for obtaining a uniform targeted volume of concentrated red blood cells
    Baxter International 1058563*

  • Implantable drug infusion device having a safety valve
    Medtronic 1058565*

  • Synthesis of epothilones, intermediates thereto and analogues thereof
    Sloan-Kettering Institute for Cancer Research 1058679*

  • Novel allylthiopyridazine derivatives and process for preparing the same
    Seoul Pharm; Kwon, Soon Kyoung 1058681*

  • Heterocyclic diarylmethylene derivatives, methods of preparing them and their uses in therapeutics
    Laboratoires Upsa 1058682*

  • Farnesyl Transferase inhibitors having a piperidine strucutre and process for preparation thereof
    LG Chemical 1058683*

  • Glycine transport inhibitors
    Janssen Pharmaceutica 1058684*

  • Nucleosides
    Medivir 1058687*

  • Specific oligonucleotide primers for detection of bovine male chromosome presence by polymerase chain reaction and method
    XY 1058688*

  • Alpha-ketoamide inhibitors of 2OS proteasome
    CV Therapeutics 1058689*

  • Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
    Apotex 1058690*

  • Caspase-8 interacting proteins
    Yeda Research and Development Company 1058691*

  • PF4 fragments and pharmaceutical compsns containing same
    Institut des Vaissaux et du Sang 1058692*

  • Process for producing farctionated pectin products
    Hercules Inc 1058693*

  • Delivery of proteins into eukaryotic cells with recombinant Yersinia
    Van der Bruggen, Pierre; Cornelis, Guy; Boland, Anne; Boon-Falleur, Thiery 1058723*

  • Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction or pharmaceutical or dietetic compsns containing such bacteria
    Mendes 1058725*

  • Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
    Centre National de la Recherche Scientifiques (CNRS) 1058726*

  • Human synapse related glycoproteins (HSRP)
    Incyte Pharmaceuticals 1058730*

  • Production of mycobacterial polypeptides by lactic acid bacteria
    Statens Seruminstitut 1058731*

  • Chimeric proteins with cell-targeted specificity and apoptosis-inducing activities
    Yissum Research Development Company of the Hebrew University of Jerusalem 1058734*
  • You may also like